Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profile

Antiviral Research
Sonia de CastroSonsoles Velázquez

Abstract

The very first TSAO derivative that lacks the 4''-amino group at the 3'-spiro moiety (compound 3) has been prepared and the effect of this modification on the activity/resistance profile has been evaluated. This molecule proved HIV-1 specific (NNRTI-characteristic). A mixture of wild-type and V106V/A or L234L/I mutations were found in the RT of some, but not all compound 3-resistant virus strains. Compound 3 does not select for the TSAO-specific E138K mutation in the RT. However, the compound markedly lost its antiviral potential against a variety of virus strains that contain NNRTI-characteristic mutations in RT including E138K. The deaminated TSAO compound must fit differently in the HIV-1 RT enzyme than its prototype TSAO-m(3)T.

References

Jun 13, 1998·Antimicrobial Agents and Chemotherapy·T FujiwaraY Hinuma
Mar 21, 2000·Medicinal Research Reviews·H JonckheereE De Clercq
Apr 5, 2000·The Journal of Antimicrobial Chemotherapy·S M Drake
Apr 12, 2002·Current Pharmaceutical Design·Giuseppe CampianiEttore Novellino
May 12, 2004·Current Topics in Medicinal Chemistry·María-José CamarasaJan Balzarini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.